April 07, 2011
Life value
STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.
To help customers learn more about methods for losing weight safely and effectively, STADA-Vietnam Joint Venture Co., Ltd. and Thanh Nien Online held together a successful online consulting of “Nutrition and Weight Loss” on April 07, 2011.
With over 400 questions sent from customers, Dr. Dao Thi Yen Phi – Head of Department of Nutrition from University of Medicine and Pharmacy Pham Ngoc Thach, and Pharmacist Nguyen Van Nhan from STADA-VN have given the safe weight-loss diet as well as how to choose the best diet pill.
STELLAPHARM is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, anti-viral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.
The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.
Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An Town, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com
With a population of more than 100 million and a total drug consumption of more than 8 billion USD in 2023, the Vietnamese pharmaceutical market is quite attractive and has a lot of potential for production and business activities. The Ministry of Health said that 2024 is a key year, with the review and amendment
Việt Nam’s pharmaceutical industry still faces many challenges and difficulties in the context of increasingly deep integration with the world, participants heard at a special seminar in Hà Nội. HÀ NỘI — Việt Nam’s pharmaceutical industry still faces many challenges and difficulties in the context of increasingly deep integration with the world, participants heard at